MaxCyte
MXCT50
$2.18arrow_drop_down2.44%-$0.05
Penny Stock
MXCT50
$2.18
arrow_drop_down2.44%Performance History
There's no data available for key stats
There's no data available for ratios/profitability stats
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
MaxCyte (MXCT)
- Sector
- Healthcare
- Industry
- Medical Devices
- CEO
- Mr. Douglas Arthur Doerfler
- Headquarters
- Rockville
- Employees
- 125
- Exchange
- NASDAQ
Keep an eye on MaxCyte
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.